10th Mar 2026 16:34
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
----------
James Cropper PLC - Kendal, England-based materials, paper and packaging group - Announces a collaboration with Hexcel on composite recycling. The two firms are working together through the aerospace & defence working group of the European Composites Circular Alliance to advance the development of high-value composite materials made from recycled carbon fibre that supports performance across aerospace, automotive and mobility sectors. "This collaboration is a significant step in advancing our aligned fibre technology into high‑performance composite markets," says James Cropper Chief Executive David Stirling. David Tilbrook, senior technical fellow at Hexcel, explains that improved fibre alignment supports stiffness-driven designs core to lightweighting and fuel burn reduction. "Fuel accounts for over 90% of an aircraft's lifetime emissions and up to 30% of airline operating costs and so weight reduction is a key environmental and economic driver," he adds.
----------
Ondine Biomedical Inc - British Columbia, Canada-based life sciences company - Says the Lantern phase 3 pivotal study, evaluating the non-antibiotic nasal photodisinfection technology (branded as Steriwave outside the US) remains on schedule to report top-line results in the spring in line with prior guidance. With 93% of patients enrolled, the study is entering its final stages of recruitment, data collection and verification, and continues to meet projected data quality and monitoring benchmarks, Ondine adds. Topline analysis will commence immediately following completion of endpoint adjudication and database lock. Chief Executive Carolyn Cross says the study represents a "landmark" investigation into universal nasal decolonisation prior to surgery and its potential to meaningfully reduce surgical site infections.
----------
Solvonis Therapeutics PLC - London-based biopharmaceutical company, focused on central nervous system disorders - Announces the selection of SVN-114 as the lead candidate from the company's proprietary SVN-SDN-14 discovery programme targeting post-traumatic stress disorder. The selection follows compelling pharmacology results from preclinical studies conducted by Evotec SE, in which SVN-114 demonstrated balanced modulation of serotonin, dopamine and noradrenaline, key brain chemicals involved in mood, emotion and social behaviour. "The identification of SVN-114 as the lead candidate from this compound series represents an important step forward for the programme," says Solvonis Chief Scientific Officer David Nutt.
----------
EnSilica PLC - Oxford, England-based computer chip maker - Provides an update on recent contract wins and programme upgrades, which it says "continues to underpin" the mid-term outlook. Notes new initial USD1.6 million contract win for life-science analysis systems with a leading UK publicly quoted life-sciences technology company. "Material" revenue contributions will commence in the financial year ending May 31, EnSilica says, with the potential of future additional long-term revenue from future production wafer supply. Further, awarded USD200,000 for a fully funded feasibility study contract by a US healthcare technology company to develop a wireless biosensing and therapeutic controller ASIC. The study is scheduled to commence in May 2026 and will run for 3 months. In addition, reports an increase in forecast demand for calendar 2026 to 2028 for its existing automotive ASIC contract with a premier global original equipment brand. This increase in volumes is expected to generate additional revenues in excess of USD4 million over 2026 and 2028. This further strengthens confidence in achieving market consensus forecasts financial year ending May as well as financial 2027, EnSilica says. Reiterates current guidance for full-year 2026 of revenues of between GBP28 million to GBP30 million, up from GBP18.2 million the year prior, and earnings before interest, tax, depreciation and amortisation of GBP3.5 million to GBP4.5 million compared to "breakeven" a year before.
----------
Ilika PLC - Romsey, England-based solid-state battery technology company - Delivers initial batch of commercial grade StereaxO electrode to Cirtec Medical for Stereax M300 production. This is the first revenue-generating order from Cirtec. "This milestone demonstrates that Ilika's facility in the UK can deliver commercial-grade electrodes to support Cirtec's M300 manufacturing activities. We look forward to ramping our supply activities to meet customer demand," says Chief Executive Graeme Purdy.
----------
Macaulay Capital PLC - provider of co-investment opportunities focused on small UK businesses - Pretax loss narrows to GBP425,089 in 2025 from GBP500,474 the year prior. Income edges up to GBP283,496 from GBP277,447, other expenses fall to GBP708,585 from GBP781,361. Loss per share is 2.82 pence compared to 4.82p. "2025 was again a somewhat disappointing year for us as we made no new company investments, despite agreeing terms and largely completing due diligence on an excellent investment opportunity in the food sector. Unfortunately, even though the necessary funds were in place, the shareholders in the private company decided at a late stage not to proceed," company says. Looking ahead, points to "a number of promising investment opportunities in our pipeline." "Our investment process is rigorous and time-consuming, and we are highly selective, but we hope to bring some of these opportunities to fruition in 2026," company adds.
----------
Rome Resources PLC - mineral explorer with tin project in Democratic Republic of the Congo - Announces a strategic expansion into Canada after entered into an option agreement to acquire working interests in early-stage exploration licences across 109 kilometre square of mining claims in the Canadian province of New Brunswick. Rome Resources considers that this option represents a "low-cost, high-potential entry point into a region with a strong pedigree for critical mineral discoveries, including tin and tungsten." Pays total CAD300,000, comprising CAD250,000 in new shares and CAD50,000 in cash, to be paid over the four years from exercise of the option. Rome Resources says the diversification aligns with its strategy to secure exposure to highly prospective critical mineral opportunities while maintaining its core commitment to advancing tin and copper resources at its flagship Bisie North project in the DRC.
----------
ATC Music Group PLC - London-based music talent management, live booking and merchandising firm previously called All Things Considered - Agrees to buy Push Media Ventures Ltd and Cirkay Ltd for total GBP1.1 million. Says this will "strengthen the group's technology and data capabilities, supporting its strategy of building a data-led, fully integrated artist services business." Push is a UK-based technology services business providing digital marketing, data analytics, fan engagement and ecommerce solutions to the music industry. Cirkay is a technology platform designed to create connections between artists and fans. Consideration consists of GBP300,000 in cash and GBP750,000 from the issue of new shares.
----------
Norman Broadbent PLC - London-based recruitment firm - Proposes a capital reduction to simplify the company's capital structure and enable the creation of distributable reserves for future use. Explains the purpose of the capital reduction is to cancel all existing deferred shares and also to cancel in full the amount standing to the credit of the company's share premium account - which stood at GBP14.2 million at January 31. Together with the cancellation of the deferred shares, around GBP20.5 million will be credited to a reserve. This reserve will first substantially eliminate the existing deficit on the P&L account, of GBP19.8 million, and then create a pool of distributable reserves. Distributable reserves may be used to absorb losses and/or to support distributions to shareholders.
----------
By Jeremy Cutler, Alliance News reporter
Comments and questions to [email protected]
Copyright 2026 Alliance News Ltd. All Rights Reserved.
Related Shares:
Cropper (J)Ondine BiomedSolvonis TherapEnsilicaIlika PlcMCAP.LRome Resources PLCNorman Broadb